Organic compounds

Details for Australian Patent Application No. 2006326255 (hide)

Owner Novartis AG

Inventors Budd, Emma; Legrand, Darren Mark; Hayler, Judy Fox; Valade, Barbara; Hatto, Julia Doris Ida

Agent Davies Collison Cave

Pub. Number AU-A-2006326255

PCT Pub. Number WO2007/068473

Priority 0525671.4 16.12.05 GB

Filing date 13 December 2006

Wipo publication date 21 June 2007

International Classifications

C07D 277/48 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/068473 Priority application(s): WO2007/068473

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326256-(2,5-dioxoimidazolidin-I-yl)-N-hydroxy-a cetamides as metalloproteinase inhibitors

2006326247-Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents